Sunlenca, Filmtabletten

7680683860011 CH-68386 Filmtabletten
Sunlenca, Filmtabletten
Sunlenca, Filmtabletten
Sunlenca, Filmtabletten
1 / 3
google

Article details

Package size
5
Selling units
5
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/10/2023
Patient information leaflet
Français
02/10/2023
Patient information leaflet
Italien
02/10/2023

Detailed composition

Substance Quantity Type Category
(N/A)
300.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 3404.75
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2024

Authorization holder

Gilead Sciences Switzerland Sàrl

6300 Zug

Authorization information

Swissmedic authorization number
68386
Drug name
Sunlenca, Filmtabletten
Galenic form
FILM
ATC Code
J05AX31
Authorization status
Z
Dispensing category
A
First authorization
07/07/2023
Authorization expiration date
06/07/2028
IT Number
08.03.0.
Domain
Human medicine
Field of application
HIV-Infektion

Package details

Description (FR)
SUNLENCA cpr pell 300 mg 5 pce
Description (DE)
SUNLENCA Filmtabl 300 mg 5 Stk
Market launch
07/07/2023
Narcotic (BTM)
No